博尔特佐米布抑制细胞增殖和炎症在一个鼠标模型的增殖性玻璃红蛋白病变
Yu-Chien Tsao1, Shun-Hua Chen2, Szu-Chi Liu2
1Department of Ophthalmology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
概括
博尔特佐米布通过抑制细胞迁移和炎症,有效治疗增殖性玻璃色素变异症 (PVR). 这种蛋白酶抑制剂显示出作为PVR的新治疗策略的承诺,PVR是视网膜脱落手术的并发症.
科学领域:
- 眼科医生 眼科 眼科
- 药理学 药理学是指药理学的学科.
- 细胞生物学 细胞生物学
背景情况:
- 增殖性视网膜病变 (PVR) 是经过风湿性视网膜脱落手术后的一种严重并发症.
- 目前对PVR的治疗方法有限,需要新的治疗方法.
研究的目的:
- 研究博特佐米布的疗效,一个蛋白酶体抑制剂,作为PVR的潜在治疗方法.
- 评估博特佐米布对参与PVR病变发生的关键细胞过程的影响及其抗炎性质.
主要方法:
- 使用ARPE-19细胞进行体外研究,以评估博雷佐米布对细胞迁移,增殖和收缩的影响.
- 使用PVR小鼠模型进行体内实验,以评估博尔特佐米布的治疗效果.
- 机制研究以阐明博尔特佐米布对NF-κB通路和炎症媒介表达的作用.
主要成果:
- 博尔特佐米布在体外显著降低了ARPE-19细胞的迁移,增殖和收缩.
- 博尔特佐米布治疗在PVR小鼠模型中显示出保护作用,减轻了临床和组织学迹象.
- 从机制上讲,博特佐米布抑制了NF-κB通路,并调节了促炎和抗炎细胞因子的表达.
结论:
- 博尔特佐米布表现出与PVR相关的显著抗增殖和抗炎作用.
- 博尔特佐米布显示出作为一种新的药理干预措施来管理增殖性玻璃红蛋白病变的潜力.
相关概念视频
Inflammation
62.1K
Overview
62.1K
Proliferative Phase
1.4K
The proliferative phase typically occurs after menstruation and lasts between 6 to 13 days in a standard 28-day cycle. This phase involves the reconstruction of the endometrium, guided by estrogen produced by the developing ovarian follicle.
Notably, the stratum basale, the basal layer of the endometrium, including the basal parts of the uterine glands, remains unaffected by menstruation. Stem cells in this layer undergo mitosis, regenerating the stratum functionalis and thickening the...
Notably, the stratum basale, the basal layer of the endometrium, including the basal parts of the uterine glands, remains unaffected by menstruation. Stem cells in this layer undergo mitosis, regenerating the stratum functionalis and thickening the...
1.4K
Feedback Inhibition
57.1K
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.1K
Abnormal Proliferation
5.2K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.2K
Enzyme Inhibition
92.4K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
92.4K
Inhibition of Cdk Activity
6.0K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.0K


